quantdetect

Hayato Hiraki, PhD, from Iwate Medical University gave a presentation on the OTS-Assay at the 85th Annual Meeting of the Japanese Cancer Association (Kyoto).

Nishizuka gave a talk on the OTS-Assay at the 85th Annual Meeting of the Japanese Cancer Association (Kyoto).

Nishizuka gave a talk on the OTS-Assay at the Special Symposium of the 46th Annual Meeting of the Japanese Society of Molecular Tumor Markers (Kyoto).

Nishizuka gave a talk on the OTS-Assay at the 8th Multi-Site Joint Medical Conference (Online).

Takeshi Iwaya, MD, PhD, from the Department of Clinical Oncology, Iwate Medical University, and Nishizuka gave a talk at ISDE2026, the 22nd World Congress for Esophageal Diseases (Kyoto).

Nishizuka gave a talk in Innovator’s Pitch Challenge at RESI SAN DIEGO 2026（San Diego, USA）。

Takeshi Iwaya, M.D., Ph.D. from the Department of Clinical Oncology, Iwate Medical University, presented an interim analysis of a prospective randomized trial using OTS-Assay (CHANGE study) at the 23rd Annual Meeting of the Japanese Society of Medical Oncology.

Ten OTS-Assay-related studies were presented at the 10th Liquid Biopsy meeting (Kyoto).

Nishizuka gave a talk in Session 2 at the 10th Liquid Biopsy 2026 meeting, sponsored by Quantdetect, Inc (Kyoto).

Nishizuka gave a talk on the OTS-Assay at the Evening Seminar of the 21st TR Workshop of the Japanese Association for Molecular Target Therapy of Cancer (Tokyo).